Skip to main content

Table 1 Baseline characteristics

From: Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm

Characteristics

All patients (n = 1359)

Demographic characteristics

 

Age (years)*

73 (59-82)

Sex (male) - no. (%)

782 (57.5)

Coexisting illnesses - no. (%)

 

Coronary heart disease

282 (20.8)

Cerebrovascular disease

110 (8.1)

Renal dysfunction

302 (22.2)

COPD

533 (39.2)

Neoplastic disease

167 (12.3)

Diabetes

231 (17.0)

Any coexisting illness

963 (70.9)

Clinical history - no. (%)

 

Cough

1164 (88.7)

Expectorations

678 (50.9)

Dyspnea

1009 (77.0)

Fever

782 (57.9)

Chills

362 (32.0)

Clinical findings

 

Confusion - no. (%)

84 (6.8)

Respiratory rate (breaths/min)*

20 (16-25)

Systolic blood pressure (mmHg)*

134 (120-150)

Heart rate (beats/minute)*

93 (80-106)

Body temperature (C°)*

37.8 (37.0-38.6)

Rales - no. (%)

832 (64.1)

Final diagnosis - no. (%)

 

Community-acquired pneumonia (CAP)

925 (68.1)

Exacerbation of COPD

228 (16.8)

Bronchitis

151 (11.1)

Other final diagnosis

55 (4.0)

  1. COPD, chronic obstructive pulmonary disease; CAP, community-acquired pneumonia; PSI, pneumonia severity index; higher PSI class refers to higher risk for mortality; *expressed as median (Interquartile range, IQR);
  2. Note: there was no statistical difference in baseline characteristic between both groups.